PRE 14A

PROXY STATEMENT

Company: ABVC BIOPHARMA, INC.
Filed: December 15, 2023
Period of Report: December 15, 2023
Accession Number: 0001213900-23-096178

View Document ↗ View on SEC.gov ↗